"휴젤, 비용 우려 딛고 중국서 '잭팟' ... 美 직판 성과도 기대할 만" https://www.hankyung.com/article/202608079828i

Channel
한경바이오인사이트
@hkbioinsight
On this record: Topic · Growth · Engagement · Posts · Citations · Cite this entry
4,296subscribers
+9 since we began measuring on 6 August 2026
Risers and fallers across the register · movement among entries of 3,162–10,000.
Register entry
| Telegram ID | -1001449199329 |
|---|---|
| Type | Channel |
| Username | @hkbioinsight |
| Created | Between 1 April 2019 and 31 October 2021 — estimated from Telegram’s id allocation, not measured. How this range is calculated. |
| First recorded | 6 August 2026 |
| Last confirmed live | 17 September 2026 |
| Measurements held | 13 |
| Confirmed unchanged | 2 times, most recently 17 September 2026 |
| On Telegram | t.me/hkbioinsight |
Topic
Other / unclassifiable — a classification, not a measurement. An on-box language model (Qwen3.6-35B-A3B-FP8, prompt version 1) read this channel’s own recent posts on 13 September 2026 and assigned it the closest of 31 fixed categories, at 94% confidence. This is a model’s judgement about what the channel is likely to be about, not a fact this register measured the way a subscriber count or a view count is measured — it can be revised on a later pass, and it carries no weight anywhere else on this page. How this classification works, and why it has no browse page of its own yet.
Growth
| Measured (UTC) | Subscribers | Change |
|---|---|---|
| 13 Sept 2026, 20:41 | 4,296 | -9 |
| 9 Sept 2026, 21:37 | 4,305 | +5 |
| 4 Sept 2026, 07:20 | 4,300 | +7 |
| 31 Aug 2026, 16:44 | 4,293 | -3 |
| 29 Aug 2026, 02:28 | 4,296 | +3 |
| 25 Aug 2026, 23:28 | 4,293 | +12 |
| 23 Aug 2026, 03:56 | 4,281 | -1 |
| 19 Aug 2026, 16:47 | 4,282 | -3 |
| 16 Aug 2026, 09:06 | 4,285 | -6 |
| 12 Aug 2026, 19:04 | 4,291 | +1 |
| 10 Aug 2026, 04:36 | 4,290 | +2 |
| 7 Aug 2026, 02:33 | 4,288 | +1 |
| 6 Aug 2026, 12:35 | 4,287 | first reading |
Engagement
28 posts held, back to 5 August 2026 — the reader has not yet reached the start of this channel’s public history, so older posts may sit further back, unread. Read across 5 pages of Telegram’s post history, 20 posts per page.
Nothing published in the last 30 days. ERR and ER are rolling 30-day measures, so there is nothing to compute — we hold 28 posts for this entry, the most recent from 7 August 2026. An engagement rate over an empty window would be a number about nothing.
Recent posts
알테오젠, 상반기 매출 1405억원·영업이익 735억원 https://www.hankyung.com/article/202608070507i
리가켐바이오, B7-H4 ADC 단독 개발 전환 https://www.hankyung.com/article/202608070502i
박셀바이오, NK세포 기반 간암 치료기술 대만 특허 등록 https://www.hankyung.com/article/202608070247i
바이오솔루션, 국립호남권생물자원관과 생물자원 개발 활성화 업무협약 https://www.hankyung.com/article/202608070237i
GC녹십자, mRNA백신 정밀 분석 기술 확보했다…국제 학술지 게재 https://www.hankyung.com/article/202608079922i
샤페론, 임시주총서 5대 1 액면병합 의결 ... 임상 전략도 공개 https://www.hankyung.com/article/202608079808i
수젠텍, 현장진단 플랫폼 캐나다 보건부 승인 ... 글로벌 사업 확장한다 https://www.hankyung.com/article/202608079798i
보령, 상반기 매출 5350억·영업이익 440억…반기 기준 역대 최대 https://www.hankyung.com/article/202608069096i
문학 야구장서 쓰러진 20대 관중, 무사히 퇴원 "수분 충분히 보충해야" https://www.hankyung.com/article/202608068833i
모더나, 세계 첫 mRNA 기반 독감 백신 시판 허가 https://www.hankyung.com/article/202608068642i
“SK바이오팜, 실적 서프라이즈에도 주가 부진…저평가 매력 부각” https://www.hankyung.com/article/202608068177i
Showing the 12 most recent of 28 posts we hold for @hkbioinsight. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.
Forward network
Republished by
Channels on the register that have forwarded this channel's posts into their own feed.
@pharmbiohana · 29,8438 posts인상주의 투자 인생 업그레이드노트
@insangnism · 11,3083 posts팔칠사공스토너 실전투자 인사이트
@stoner8740 · 11,0353 postsBUY(!)BUY(!)바이오🤡DS 제약/바이오 김민정
@mnJeong_BIO · 7,8962 posts일타강사 ’제약/바이오‘ 투자 길라잡이
@K_biopharma1st · 4,6211 post바이오 탐색대
@PathfinderOfBio · 1,1071 post텐렙
@Ten_level · 17,1331 postYeouido Lab_여의도 톺아보기
@Yeouido_Lab · 43,3091 post찹츄만판당🎤
@alienorinc · 5381 post[IV리서치] 제약/바이오
@buy_oh · 3111 post6해치 투자 운영
@hatcherysix · 5,1081 post호그니엘
@hogniel · 15,3271 post
Built only from forwarded posts we have actually read, on both sides. Coverage is early and deliberately incomplete: a missing link means we have not read the post that would prove it, never that the relationship does not exist. Counts are distinct forwarded posts observed, so they only ever go up as we read more.
Cite this entry
A live page changes as we take new readings, so a citation should name the measurement it is based on, not just the URL. The line below cites the subscriber count as measured 13 September 2026 — this entry's latest reading, not the date you are reading this.
“한경바이오인사이트” (@hkbioinsight), 4,296 subscribers as measured 13 September 2026. Telegram Register, tgregister.com/channel/hkbioinsight.
Full measurement history, CC BY 4.0. Every reading this register holds for this entry, not just the latest one, as a dated, downloadable record: CSV · JSON. Free to use with attribution to tgregister.com. Each file carries its own generation timestamp, which is the figure to cite for exactly when the data was retrieved.